{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:33:51Z","timestamp":1788780831277,"version":"build-2803163510"},"reference-count":47,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,3,12]]},"DOI":"10.3233\/jad-180816","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T11:39:05Z","timestamp":1549625945000},"page":"267-279","source":"Crossref","is-referenced-by-count":33,"title":["Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer\u2019s Disease and Subcortical Ischemic Vascular Disease: A Systematic Review"],"prefix":"10.1177","volume":"68","author":[{"given":"Christina","family":"Manniche","sequence":"first","affiliation":[{"name":"Department of Neurology, Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen OE, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hejl","sequence":"additional","affiliation":[{"name":"Department of Neurology, Bispebjerg Hospital, Copenhagen NV, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steen Gregers","family":"Hasselbalch","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen OE, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja Hviid","family":"Simonsen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Dementia Research Centre, Rigshospitalet, University of Copenhagen, Copenhagen OE, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180816_ref1","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.3171\/2016.7.FOCUS16194","article-title":"Imaging normal pressure hydrocephalus: Theories, techniques, and challenges","volume":"41","author":"Keong","year":"2016","journal-title":"Neurosurg Focus"},{"key":"10.3233\/JAD-180816_ref2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000328924","article-title":"Cognitive profile of idiopathic normal pressure hydrocephalus","volume":"1","author":"Saito","year":"2011","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.3233\/JAD-180816_ref3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/jnnp.67.1.66","article-title":"White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer\u2019s disease, vascular dementia, and normal aging","volume":"67","author":"Barber","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-180816_ref4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.25046","article-title":"Deconstructing normal pressure hydrocephalus: Ventricu-lomegaly as early sign of neurodegeneration","volume":"82","author":"Espay","year":"2017","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-180816_ref5","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1212\/WNL.0000000000002193","article-title":"Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of response","volume":"85","author":"Halperin","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-180816_ref6","first-page":"e1000097","article-title":"Preferred reporting items for systematic reviews and metaanalyses: The PRISMA Statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoSMed"},{"key":"10.3233\/JAD-180816_ref7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jnnp.54.3.252","article-title":"CSF monoamine metabolites, cholinesterases and lactate in the adult hydrocephalus syndrome (normal pressure hydrocephalus) related to CSF hydrodynamic parameters","volume":"54","author":"Malm","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-180816_ref8","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1136\/jnnp.2003.026013","article-title":"Meningeal derived cerebrospinal fluid proteins in different forms of dementia: Is a meningopathy involved in normal pressure hydrocephalus?","volume":"75","author":"Brettschneider","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-180816_ref9","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2010.07.011","article-title":"Biochemical studies in normal pressure hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (A\u03b2) peptide and phospho-tau","volume":"45","author":"Ray","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-180816_ref10","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.neurobiolaging.2011.02.023","article-title":"A unique N-glycan on human transferrin in CSF: A possible biomarker for iNPH","volume":"33","author":"Futakawa","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180816_ref11","doi-asserted-by":"crossref","first-page":"e91974","DOI":"10.1371\/journal.pone.0091974","article-title":"Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus","volume":"9","author":"Pyykk\u00f6","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-180816_ref12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12987-016-0037-y","article-title":"Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus","volume":"13","author":"Jeppsson","year":"2016","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-180816_ref13","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-180816_ref14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","article-title":"CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus","volume":"116","author":"Aagren-Wilsson","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-180816_ref15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jnnp.69.1.74","article-title":"CSF sulfatide distinguishes between normal pressure hydro-cephalus and subcortical arteriosclerotic encephalopathy","volume":"69","author":"Tullberg","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-180816_ref16","first-page":"586","article-title":"Selected pro-and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus","volume":"35","author":"Sosvorova","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"key":"10.3233\/JAD-180816_ref17","first-page":"1000150","article-title":"Differences in cerebrospinal fluid biomarkers between clinically diagnosed idiopathic normal pressure hydrocephalus and Alzheimer\u2019s disease","volume":"4","author":"Tsai","year":"2015","journal-title":"J Alzheimers Dis Parkinsonism"},{"key":"10.3233\/JAD-180816_ref18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40364-018-0119-x","article-title":"Comparative analysis of cerebrospinal fluid metabolites in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort","volume":"6","author":"Nagata","year":"2018","journal-title":"Biomark Res"},{"key":"10.3233\/JAD-180816_ref19","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3892\/mmr.2017.7015","article-title":"PTPRQ as a potential biomarker for idiopathic normal pressure hydrocephalus","volume":"16","author":"Nagata","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.3233\/JAD-180816_ref20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3233\/JAD-180059","article-title":"Change of amyloid-\u03b2 1-42 toxic conformer ratio after cerebrospinal fluid diversion predicts long-term cognitive outcome in patients with idiopathic normal pressure hydrocephalus","volume":"63","author":"Akiba","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180816_ref21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-170186","article-title":"Cerebrospinal fluid amyloid-\u03b2 42, total tau and phosphorylated tau are low in patients with normal pressure hydrocephalus: Analogies and differences with Alzheimer\u2019s disease","volume":"60","author":"Santangelo","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180816_ref22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-142622","article-title":"Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer\u2019s disease","volume":"45","author":"Jingami","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180816_ref23","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","article-title":"Soluble amyloid precursor protein a in the 4 cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus","volume":"20","author":"Miyajima","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-180816_ref24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and \u03b2-amyloid 1-42 in idiopathic normal pressure hydrocephalus: A discrimination from Alzheimer\u2019s disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-180816_ref25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00702-003-0075-x","article-title":"Immunoreactivities of amyloid beta peptide (1-42) and total tau protein in lumbar cerebrospinal fluid of patients with normal pressure hydrocephalus","volume":"111","author":"Lins","year":"2004","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-180816_ref26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2015.00086","article-title":"A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus","volume":"6","author":"Schirinzi","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-180816_ref27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2377-14-66","article-title":"Evaluation of coexistence of Alzheimer\u2019s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers","volume":"14","author":"Lim","year":"2014","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-180816_ref28","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jsbmb.2015.05.004","article-title":"Steroid hormones in prediction of normal pressure hydrocephalus","volume":"152","author":"Sosvorova","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.3233\/JAD-180816_ref29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2006.11.039","article-title":"Expression of TGF-\u03b2s and TGF-\u03b2 type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus","volume":"413","author":"Li","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-180816_ref30","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00701-006-0787-4","article-title":"Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics","volume":"148","author":"Li","year":"2006","journal-title":"Acta Neurochir"},{"key":"10.3233\/JAD-180816_ref31","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0006-3223(96)00098-4","article-title":"Decreased cholecystokinin levels in cerebrospinal fluid of patients with adult chronic hydrocephalus syndrome","volume":"41","author":"Galard","year":"1997","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-180816_ref32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1600-0404.2012.01677.x","article-title":"A new scale for assessment of severity and outcome in iNPH","volume":"126","author":"Hellstr\u00f6m","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"Suppl","key":"10.3233\/JAD-180816_ref33","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2176\/nmc.48.S1","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus","volume":"48","author":"Ishikawa","year":"2008","journal-title":"Neurol Med Chir"},{"key":"10.3233\/JAD-180816_ref34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1227\/01.NEU.0000168185.29659.C5","article-title":"INPH guidelines, part II: Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.3233\/JAD-180816_ref35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2176\/nmc.52.775","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus: Second edition","volume":"52","author":"Mori","year":"2012","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"10.3233\/JAD-180816_ref36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2015.00143","article-title":"Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer\u2019s disease: The issue of diurnal variation","volume":"6","author":"Cicognola","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-180816_ref37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2217\/bmm.12.46","article-title":"Recommendations to standardize preanalytical confounding factors in Alzheimer\u2019s and Parkinson\u2019s disease cerebrospinal fluid biomarkers: An update","volume":"6","author":"del Campo","year":"2012","journal-title":"Biomark Med"},{"key":"10.3233\/JAD-180816_ref38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12987-017-0062-5","article-title":"Cerebrospinal fluid A\u03b242, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydro-cephalus: A systematic review and meta-analysis","volume":"14","author":"Chen","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-180816_ref39","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.68.6.778","article-title":"Alzheimer\u2019s disease comorbidity in normal pressure hydrocephalus: Prevalence and shunt response","volume":"68","author":"Golomb","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-180816_ref40","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s007010050353","article-title":"Shunting effects in patients with idiopathic normal pressure hydrocephalus; correlation with cerebral and lep-tomeningeal biopsy findings","volume":"141","author":"Bech","year":"1999","journal-title":"Acta Neurochir (Wien)"},{"key":"10.3233\/JAD-180816_ref41","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3233\/JAD-150909","article-title":"High risk of dementia in ventricular enlargement with normal pressure hydrocephalus related symptoms","volume":"52","author":"Koivisto","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180816_ref42","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/brain\/awh131","article-title":"Pattern of white matter regional cerebral blood flow and autoregulation in normal pressure hydrocephalus","volume":"127","author":"Momjian","year":"2004","journal-title":"Brain"},{"key":"10.3233\/JAD-180816_ref43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/joim.12816","article-title":"Biomarkers for Alzheimer\u2019s disease: Current status and prospects for the future","volume":"284","author":"Blennow","year":"2018","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-180816_ref44","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.0000000000000916","article-title":"Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-180816_ref45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02688697.2016.1229749","article-title":"Incidence and outcome of surgery for adult hydrocephalus patients in Sweden","volume":"31","author":"Sundstr\u00f6m","year":"2017","journal-title":"Br J Neurosurg"},{"key":"10.3233\/JAD-180816_ref46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00415-017-8680-z","article-title":"Long-term effects of complications and vascular comorbidity in idio-pathic normal pressure hydrocephalus: A quality registry study","volume":"265","author":"Andr\u00e9n","year":"2018","journal-title":"J Neurol"},{"key":"10.3233\/JAD-180816_ref47","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1227\/01.NEU.0000168187.01077.2F","article-title":"Outcome of shunting in idiopathic normal-pressure hydrocephalus and the value of outcome assessment in shunted patients","volume":"57","author":"Klinge","year":"2005","journal-title":"Neurosurgery"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:03Z","timestamp":1777370943000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180816"}},"subtitle":[],"editor":[{"given":"Masatsune","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,12]]},"references-count":47,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-180816","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,12]]}}}